Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Robert Segal"'
Autor:
Ronnie Shapira-Frommer, Robert Segal, Gal Markel, Nethanel Asher, Ayala Tamir, Hagit Harati, Ronen Stoff, Shirly Grynberg, Adam Ostrowski, Lawrence Florin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/2ac901a7449f435f9fa9ba8ed5696e81
Autor:
Fernando R. Moya, Jan Mazela, Paul M. Shore, Steven G. Simonson, Robert Segal, Phillip D. Simmons, Timothy J. Gregory, Carlos G. Guardia, Judy R. Varga, Neil N. Finer, on behalf of the Preterm Neonate Early Respiratory Management Prospective Observational Study investigators
Publikováno v:
BMC Pediatrics, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Current guidelines for management of respiratory distress syndrome (RDS) recommend continuous positive airway pressure (CPAP) as the primary mode of respiratory support even in the most premature neonates, reserving endotracheal i
Externí odkaz:
https://doaj.org/article/980b579d4ba2448dba2514321e4a2526
Autor:
Catherine M. Ludwig, Alyssa M Thompson, Bryan Kromenacker, Tiffany Y. Loh, Robert Segal, Vivian Y. Shi
Publikováno v:
International Journal of Women's Dermatology, Vol 6, Iss 3, Pp 235- (2020)
Externí odkaz:
https://doaj.org/article/06de60c12b714421942b7b8f881e1ea0
Autor:
Helen Levey Bernie, DO, MPH, Robert Segal, MD, Brian Le, MD, Arthur Burnett, MD, MBA, Trinity J. Bivalacqua, MD, PhD
Publikováno v:
Sexual Medicine, Vol 5, Iss 1, Pp e31-e36 (2017)
Introduction: Intracavernosal injection (ICI) therapy is widely used for the treatment of erectile dysfunction (ED). Its use in practice is largely empirical and has not been validated with evidence-based approaches. Aim: To compare two strategies fo
Externí odkaz:
https://doaj.org/article/b84d1a59961b4813985dfcef6b0d46ab
Autor:
Robert Segal, Arthur L. Burnett
Publikováno v:
Therapeutic Advances in Urology, Vol 3 (2011)
Prostate cancer is the most common cancer among men, representing approximately 25% of all new cancer diagnoses in the USA. For clinically localized prostate cancer, the gold standard for therapy remains radical prostatectomy. One of the main adverse
Externí odkaz:
https://doaj.org/article/dfea6ac7b4634717ab0dda3976e718a7
Autor:
Robert Segal
Publikováno v:
Revista Thesis Juris. 11:258-282
Esse artigo tem como objetivo apresentar uma discussão sobre a ética jurídica na advocacia colaborativa, como parte de um sistema multiportas de acesso à justiça e tomando como referencial teórico as abordagens de Luban e Wendel (2017), Webb e
Autor:
Steven Josephs, Robert Segal, Steve Prince, Mathew Ong, Amir Jafri, Lawrence Florin, Victoria Manax, Michael Matho, Sameera Bilgrami, Annette Marleau
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Piotr J. Wysocki, Piotr Tomczak, Tomasz Jankowski, Tomasz Nowikiewicz, Gal Markel, Ronnie Shapira, Gokhan Demir, Mustafa Bozkurt, Sameera Bilgrami, Annette Marleau, Adam Ostrowski, Lawrence Florin, Victoria Manax, Robert Segal
Publikováno v:
Cancer Research. 83:4426-4426
Immunicom, Inc. has developed a novel subtractive immunotherapeutic apheresis method (Immunopheresis®) to selectively remove soluble tumor necrosis factor receptors, sTNF-R1 and sTNF-R2 (sTNF-Rs) generated by tumors. sTNF-Rs block the tumoricidal ac
Autor:
John R. Teerlink, Xiumin Han, Phillip D. Simmons, Gabriella Malfatto, Maria Teresa La Rovere, Benjamin Li, Zuyi Yuan, Marco Metra, Dianfu Li, Yuhui Zhang, Giuseppe Bianchi, Jian Zhang, Christopher M. O'Connor, Yali Yao, G. Michael Felker, Gerasimos Filippatos, Carlo Lombardi, Valentina Carubelli, Lit Fui Lau, Robert Segal
Publikováno v:
European Journal of Heart Failure. 22:1684-1693
Aim Istaroxime is a first-in-class agent which acts through inhibition of the sarcolemmal Na+ /K+ pump and activation of the SERCA2a pump. This study assessed the effects of a 24 h infusion of istaroxime in patients hospitalised for acute heart failu
Autor:
Piotr Jan Wysocki, Adam Ostrowski, Robert Segal, Victoria Manax, Pawel Potocki, Kamil Konopka, Lukasz Kwinta, Paulina Fraczek, Maciej Lubas, Mateusz Lobacz, Lawrence Florin
Publikováno v:
Cancer Research. 82:CT179-CT179
Introduction: Tumor necrosis factor-alpha (TNFα) is a pleiotropic cytokine with known antitumor activity, produced mainly by activated immune cells. Cancer cells neutralize TNFα by shedding soluble TNF receptors 1&2 (sTNF-Rs), which act as TNFα-bi